Navigation Links
Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints
Date:6/18/2013

CHAPEL HILL, N.C., June 18, 2013 /PRNewswire/ -- Recent regulatory and budget challenges have made it more and more difficult for Medical Education groups at large pharmaceutical companies to effectively educate doctors and other healthcare practitioners on the safe and effective use of their new products. With the pressure to reduce budgets mounting within the pharma industry, it is crucial that these "Med Ed" groups find practical, economical methods of reaching healthcare professionals.

To address the changes that are transforming the Medical Education area throughout the healthcare landscape, research and consulting firm Best Practices, LLC developed the critical new study "Benchmarking Critical Program Trends Transforming the Medical Device and Biopharmaceutical Marketplace." This field research investigates emerging trends regarding funding, delivery channels, program effectiveness, and value drivers related to the Medical Education function.

Key study topics include:

  • Funding channels utilized by Medical Education groups
  • Effectiveness of different Medical Education program types and delivery channels
  • Use of multi-disciplinary Medical Education programs
  • Trends in grants to professional societies/associations for accredited and non-accredited education programs 
  • Rating of company professionals most valued by physicians for education
  • Future trends in Medical Education programs and technology

The full 120-page report contains over 500 valuable benchmark metrics that will equip executives with the critical data needed to make informed decisions. The study identifies current program and funding trends that will allow Medical Education leadership to evaluate their organization's resource levels relative to other market leaders.

This benchmarking research drew participation from 32 Medical Education executives and managers from 31 leading global pharmaceutical and medical device companies. In addition, deep-dive interviews were conducted with five selected respondents to gather additional insights.

To learn more about this report, download a complimentary report excerpt by visiting http://www.best-in-class.com/rr1218.htm. For more information on other recent primary research studies, contact us at 919.403.0251, or visit our website at http://www.best-in-class.com/. Check out our new blog at http://whybenchmarking.com/ for more industry trends and topics!

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

 

 

 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
2. TMG Health To Present Kip Piper at Thought Leadership Dinner
3. GDS Internationals Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
4. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
5. Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
6. Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer
7. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
8. Though Over One-Third of Rheumatologists Have Prescribed Xeljanz for Their Rheumatoid Arthritis Patients, Physicians are Still Concerned With the Drugs Limited Post-Marketing Experience and Risks of Infection and Malignancy
9. In Pretreated Advanced Renal Cell Carcinoma, Thought Leaders Opinions and Clinical Data Indicate that Tivopath Has Efficacy and Tolerability Advantages Over Currently Used Therapies
10. For Osteoporosis and Osteopenia, Clinical Data and Thought Leaders Opinions Indicate that AMG-785/CDP-7851 and Odanacatib Have Advantages Over Alendronate
11. In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided ... Piedras, Puerto Rico , where the ... Following a comprehensive onsite ... structural damage, temporary loss of power and minimal water ... manufacturing operations have resumed, and the company expects to ...
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
Breaking Medicine News(10 mins):